ClinicalTrials.Veeva

Menu

Preoperative Comprehensive Geriatric Assessment (CGA) and Postoperative Delirium

University of Miami logo

University of Miami

Status

Enrolling

Conditions

CGA

Treatments

Other: control
Behavioral: CGA

Study type

Interventional

Funder types

Other

Identifiers

NCT07059585
20230790

Details and patient eligibility

About

The purpose of this research is to find out the best way to reduce delirium in frail, older patients undergoing planned surgery. Delirium is a state of confusion and difficulty concentrating that is temporary. Delirium may make the person anxious, angry, sleepy, not think clearly, or hallucinate. Being frail in medicine means that the body may not easily recover from a stressor, such as surgery. This study will determine if a detailed on-going evaluation by a Geriatrician, doctor who specializes in the care of older adults, after surgery is better at decreasing the risk of delirium than simply highlighting the patient's frailty in the electronic medical record.

Enrollment

200 estimated patients

Sex

All

Ages

60+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Frailty as measured by the 5-modified frailty index (5-mFI) during the anesthesia preoperative assessment. The 5-mFI consists of 5 elements: 1-dependency for activities of daily living, 2-congestive heart failure within 30 days, 3-chronic obstructive pulmonary disease or pneumonia currently treated with antibiotics, 4-diabetes, and 5-hypertension. The diagnosis of frailty by the 5-mFI is based upon the presence of 2 or more of the elements.
  2. Elective inpatient surgery with an expected LOS > 1 day;
  3. Receiving general anesthesia
  4. Adults who are unable to consent if they have a designated proxy able to consent

Exclusion criteria

  1. Absence or withdrawal of informed consent,
  2. Presence of current delirium
  3. prisoners

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

200 participants in 2 patient groups

CGA group
Experimental group
Description:
Participants will receive the CGA intervention for up to 2 weeks
Treatment:
Behavioral: CGA
Control Group
Other group
Description:
Participants will receive standard of care treatment for up to 2 weeks
Treatment:
Other: control

Trial contacts and locations

1

Loading...

Central trial contact

Elizabeth Gabrielli, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems